BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26788118)

  • 1. Increasing the Time Interval between PCV Chemotherapy Cycles as a Strategy to Improve Duration of Response in Low-Grade Gliomas: Results from a Model-Based Clinical Trial Simulation.
    Mazzocco P; Honnorat J; Ducray F; Ribba B
    Comput Math Methods Med; 2015; 2015():297903. PubMed ID: 26788118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
    Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
    J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centre.
    Keogh RJ; Aslam R; Hennessy MA; Coyne Z; Hennessy BT; Breathnach OS; Grogan L; Morris PG
    BMC Cancer; 2021 Feb; 21(1):140. PubMed ID: 33557783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas.
    Jakacki RI; Jamison C; Mathews VP; Heilman DK; Dropcho E; Cornetta K; Macdonald DR; Williams DA
    Med Pediatr Oncol; 1998 Dec; 31(6):483-90. PubMed ID: 9835900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
    Levin VA
    Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas.
    Peyre M; Cartalat-Carel S; Meyronet D; Ricard D; Jouvet A; Pallud J; Mokhtari K; Guyotat J; Jouanneau E; Sunyach MP; Frappaz D; Honnorat J; Ducray F
    Neuro Oncol; 2010 Oct; 12(10):1078-82. PubMed ID: 20488959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial.
    Medical Research Council Brain Tumor Working Party
    J Clin Oncol; 2001 Jan; 19(2):509-18. PubMed ID: 11208845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802.
    Shaw EG; Wang M; Coons SW; Brachman DG; Buckner JC; Stelzer KJ; Barger GR; Brown PD; Gilbert MR; Mehta MP
    J Clin Oncol; 2012 Sep; 30(25):3065-70. PubMed ID: 22851558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
    Levin VA; Silver P; Hannigan J; Wara WM; Gutin PH; Davis RL; Wilson CB
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy in low-grade gliomas.
    Viaccoz A; Lekoubou A; Ducray F
    Curr Opin Oncol; 2012 Nov; 24(6):694-701. PubMed ID: 22913972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial.
    Taphoorn MJ; van den Bent MJ; Mauer ME; Coens C; Delattre JY; Brandes AA; Sillevis Smitt PA; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; Allgeier A; Bottomley A;
    J Clin Oncol; 2007 Dec; 25(36):5723-30. PubMed ID: 18089866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
    Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK
    Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas.
    Jeremic B; Jovanovic D; Djuric LJ; Jevremovic S; Mijatovic LJ
    J Chemother; 1992 Apr; 4(2):123-6. PubMed ID: 1321239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02.
    Prabhu RS; Won M; Shaw EG; Hu C; Brachman DG; Buckner JC; Stelzer KJ; Barger GR; Brown PD; Gilbert MR; Mehta MP
    J Clin Oncol; 2014 Feb; 32(6):535-41. PubMed ID: 24419119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procarbazine--a traditional drug in the treatment of malignant gliomas.
    Goerne R; Bogdahn U; Hau P
    Curr Med Chem; 2008; 15(14):1376-87. PubMed ID: 18537615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
    Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1147-52. PubMed ID: 15001257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-intensive, time-compressed procarbazine, CCNU, vincristine (PCV) with peripheral blood stem cell support and concurrent radiation in patients with newly diagnosed high-grade gliomas.
    Jakacki RI; Siffert J; Jamison C; Velasquez L; Allen JC
    J Neurooncol; 1999 Aug; 44(1):77-83. PubMed ID: 10582673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine.
    Webre C; Shonka N; Smith L; Liu D; De Groot J
    Anticancer Res; 2015 Oct; 35(10):5467-72. PubMed ID: 26408710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.